Blachier, S., Vaney, M., Conquet, L., Staropoli, I., Fernández, I., Giraud, E., Arbabian, A., Michel, V., Szilagyi, F., Guez, S., Boucharlat, A., Chiaravalli, J., Tran-Rajau, J., Dufour, E., Haouz, A., Petres, S., Planas, D., Montagutelli, X., Agou, F., Lafaye, P., Aymé, G., Schwartz, O., Rey, F. A., Enninga, J., Brelot, A. (2025). Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo. Nature Communications. https://doi.org/10.1038/s41467-025-65144-w